Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice

Rationale: Daily rifapentine plus isoniazid-pyrazinamide in mice infected with Mycobacterium tuberculosis produces cure in 3 months. Whether cure corresponds to latent infection contained by host immunity or true tissue sterilization is unknown.


Published in:
American Journal Of Respiratory And Critical Care Medicine, 183, 1254-1261
Year:
2011
Keywords:
Laboratories:




 Record created 2011-12-16, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)